By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS


Industry
Pharmaceutical






Company News
RedHill Biopharma Ltd. (RDHL) Receives Notice of Allowance For Two Additional U.S. Patents Covering RHB-104 Ongoing Phase III Crohn's Disease Program 7/1/2015 6:57:23 AM
RedHill Biopharma Ltd. (RDHL) Initiates Phase I/II Study Of ABC294640 For Refractory Lymphoma 6/29/2015 7:26:44 AM
BIO2015: RedHill Biopharma Ltd. (RDHL) To Present At The 2015 BIO International Convention 6/16/2015 10:45:21 AM
RedHill Biopharma Ltd. (RDHL) Announces Acceptance Of Phase III Trial Application In Europe With RHB-104 For Crohn's Disease 6/16/2015 8:09:22 AM
RedHill Biopharma Ltd. (RDHL) To Host Conference Call Today To Review Positive Phase III Top-Line Results With RHB-105 For H. Pylori Infection 6/15/2015 7:53:37 AM
RedHill Biopharma Ltd. (RDHL) Successfully Meets Primary Endpoint In Phase III Study Of RHB-105 For H. Pylori Infection 6/15/2015 5:54:36 AM
RedHill Biopharma Ltd. (RDHL) Announces Completion Of Patient Enrollment In The Phase IIa Study Of RHB-104 For Multiple Sclerosis 6/9/2015 7:23:49 AM
RedHill Biopharma Ltd. (RDHL) Completes Treatment Of Last Patient With RHB-105 In Phase III Study 6/8/2015 7:44:18 AM
RedHill Biopharma Ltd. (RDHL) Provides Update On Development Pipeline And Expected Timing For RHB-105 Phase III Top-Line Results 6/3/2015 7:14:05 AM
RedHill Biopharma Ltd. (RDHL) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/27/2015 7:25:26 AM
12345678910...
//-->